Mickael Tordjman1, Laetitia Perronne2, Guillaume Madelin2, Rahul D Mali2, Christopher Burke3. 1. Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, 10016, USA. mickael_tordjman@hotmail.com. 2. Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, 10016, USA. 3. Department of Radiology, Langone Orthopedic Hospital, 301 East 17th St, New York, 10021, USA.
Abstract
OBJECTIVES: CT-guided radiofrequency ablation (CT-RFA) is considered to be the gold standard for treatment of osteoid osteoma (OO) yet treatment failures (TFs) continue to be reported. This systematic review was conducted to evaluate factors associated with TF, such as ablation time, lesion location, and patient age as well as evaluating how TF has trended over time. METHODS: Original studies reporting on patients undergoing CT-RFA of OO published between 2002 and 2019 were identified. TF was defined as patients with (1) recurrent or persistent pain +/- (2) imaging evidence of persistent OO. TFs were subdivided into those occurring after the index procedure (primary TF) or those occurring after repeat RFA (secondary TF). Subgroup analysis was performed for TF based on the study date (2002-2010 or 2010-2019), time duration of ablation at 90 °C (6 min or > 6 min), patient age, and tumor location (spinal vs. appendicular). RESULTS: Sixty-nine studies were included for a total of 3023 patients. The global primary TF rate was 8.3% whereas the secondary TF rate was 3.1%. The TF rate reported in studies published after 2011(7%) was about half that during the earlier time period 2002-2010 (14%). There was no statistical difference in TF corrected for age, OO location, or duration of ablation (respectively p = 0.39, 0.13, and 0.23). The global complication rate was 3%, the most frequent being skin burns (n = 24; 0.7%). CONCLUSIONS: A decrease in TF observed between 2011-2019 compared to 2002-2010 may reflect improvements in operator technique or advancements in equipment. Duration of ablation, patient age, or location of OO failed to significantly correlate with TF. KEY POINTS: • CT-guided radiofrequency ablation of osteoid osteomas is a safe technique with a low rate of treatment failure (8.3% failure rate after the primary radiofrequency reducing to 3.1% following a secondary treatment). • The treatment failure rate has decreased over time, possibly due to an improved understanding of the disease process, better technique, and advances in equipment. • Duration of ablation, patient age, or lesion location did not significantly correlate with treatment failure.
OBJECTIVES: CT-guided radiofrequency ablation (CT-RFA) is considered to be the gold standard for treatment of osteoid osteoma (OO) yet treatment failures (TFs) continue to be reported. This systematic review was conducted to evaluate factors associated with TF, such as ablation time, lesion location, and patient age as well as evaluating how TF has trended over time. METHODS: Original studies reporting on patients undergoing CT-RFA of OO published between 2002 and 2019 were identified. TF was defined as patients with (1) recurrent or persistent pain +/- (2) imaging evidence of persistent OO. TFs were subdivided into those occurring after the index procedure (primary TF) or those occurring after repeat RFA (secondary TF). Subgroup analysis was performed for TF based on the study date (2002-2010 or 2010-2019), time duration of ablation at 90 °C (6 min or > 6 min), patient age, and tumor location (spinal vs. appendicular). RESULTS: Sixty-nine studies were included for a total of 3023 patients. The global primary TF rate was 8.3% whereas the secondary TF rate was 3.1%. The TF rate reported in studies published after 2011(7%) was about half that during the earlier time period 2002-2010 (14%). There was no statistical difference in TF corrected for age, OO location, or duration of ablation (respectively p = 0.39, 0.13, and 0.23). The global complication rate was 3%, the most frequent being skin burns (n = 24; 0.7%). CONCLUSIONS: A decrease in TF observed between 2011-2019 compared to 2002-2010 may reflect improvements in operator technique or advancements in equipment. Duration of ablation, patient age, or location of OO failed to significantly correlate with TF. KEY POINTS: • CT-guided radiofrequency ablation of osteoid osteomas is a safe technique with a low rate of treatment failure (8.3% failure rate after the primary radiofrequency reducing to 3.1% following a secondary treatment). • The treatment failure rate has decreased over time, possibly due to an improved understanding of the disease process, better technique, and advances in equipment. • Duration of ablation, patient age, or lesion location did not significantly correlate with treatment failure.
Entities:
Keywords:
Bone neoplasms; Osteoid osteoma; Radiofrequency ablation; Radiofrequency therapy
Authors: Göran Dellgren; Andreas Westerlind; Hans Liden; Jakob Gäbel; Sven-Erik Bartfay; Entela Bollano; Erik Holmberg; Bert Andersson; Henrik Schersten; Kristjan Karason Journal: Int J Cardiol Date: 2017-01-04 Impact factor: 4.164
Authors: Thomas Beyer; Carla S P van Rijswijk; Jose Martel Villagrán; Christoph Rehnitz; Mario Muto; Christian von Falck; Jan Gielen; Kolja M Thierfelder; Marc-André Weber Journal: Neuroradiology Date: 2019-06-03 Impact factor: 2.804
Authors: L G Morassi; K Kokkinis; D S Evangelopoulos; O Karargyris; I Vlachou; K Kalokairinou; S G Pneumaticos Journal: Br J Radiol Date: 2014-04-09 Impact factor: 3.039
Authors: Joe Faddoul; Yara Faddoul; Sandra Kobaiter-Maarrawi; Ronald Moussa; Tony Rizk; Georges Nohra; Nabil Okais; Elie Samaha; Joseph Maarrawi Journal: J Neurosurg Spine Date: 2016-12-02